Arcutis Biotherapeutics (NASDAQARQT) Stock Price Expected to Rise, Mizuho Analyst Says

News Source : ETF Daily News
News Summary
- Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Mizuho from $19
- 00 to $20
- 00 in a research note released on Tuesday
- They currently have an outperform rating on the stock
- The company had revenue of $44
- 76 million during the quarter, compared to analyst estimates of $38
- 05 million
Arcutis Biotherapeutics (NASDAQARQT Free Report) had its price target lifted by Mizuho from $19.00 to $20.00 in a research note released on Tuesday,Benzinga reports. They currently have an outperf [+5037 chars]